Study shows cholesterol-lowering drug reduces diabetic retinopathy risk
An estimated 27% of patients globally living with diabetes will be affected by retinopathy
Read Moreby Jen Brogan | Jun 25, 2024 | News | 0
An estimated 27% of patients globally living with diabetes will be affected by retinopathy
Read Moreby John Pinching | Aug 2, 2022 | News | 0
System improves management for people with diabetes by offering finger prick-free monitoring
Read Moreby John Pinching | Jul 7, 2022 | News | 0
The British Heart Foundation’s project will accelerate the search for better prevention and treatment of diabetes
Read Moreby John Pinching | May 10, 2022 | News | 0
Researchers reviewed findings from 158 global studies to determine how COVID-19 affects people living with diabetes
Read Moreby John Pinching | Apr 26, 2022 | News | 0
The Foundation also launched a new collaboration with Diabetes UK and the Juvenile Diabetes Research Foundation UK
Read Moreby John Pinching | Apr 1, 2022 | News | 0
New technology could reduce finger pricking by 50% while also providing patients with continuous data about blood sugar levels
Read Moreby John Pinching | Mar 29, 2022 | News | 0
Charter for Change examines reasons for inequalities and sets out recommendations to improve diabetes care
Read Moreby Selina McKee | Sep 1, 2020 | News | 0
Rybelsus is the world’s first and only oral GLP-1 receptor agonist
Read Moreby Selina McKee | Jun 18, 2020 | News | 0
The drug was shown to be as safe as placebo on a composite of CV death, nonfatal myocardial infarction or nonfatal stroke
Read Moreby Selina McKee | Jun 10, 2020 | News | 0
The tools are designed to help people manage their condition during the coronavirus pandemic
Read Moreby Selina McKee | Jun 2, 2020 | News | 0
New Brilinta indication expands treatment to high-risk coronary patients without a history of stroke or heart attack
Read Moreby Selina McKee | May 27, 2020 | News | 0
The Defeat Diabetes includes a number of initiatives to provide access to affordable care to vulnerable patients and accelerate prevention to halt the rise of the disease
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
